M-END Interactions
There are 768 drugs known to interact with M-END (brompheniramine / hydrocodone / pseudoephedrine), along with 26 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 224 are major, 536 are moderate, and 8 are minor.
- View all 768 medications that may interact with M-END
- View M-END alcohol/food interactions (2)
- View M-END disease interactions (26)
Most frequently checked interactions
View interaction reports for M-END (brompheniramine / hydrocodone / pseudoephedrine) and the medicines listed below.
- Actos (pioglitazone)
- Alcohol (contained in alcoholic beverages) (ethanol)
- allopurinol
- beetroot
- Betoptic S (betaxolol ophthalmic)
- Bystolic (nebivolol)
- Celebrex (celecoxib)
- cinnamon
- clindamycin
- CoQ10 (ubiquinone)
- Depo-Testosterone (testosterone)
- Dexilant (dexlansoprazole)
- Diovan HCT (hydrochlorothiazide / valsartan)
- finasteride
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- horny goat weed
- hydrochlorothiazide
- L-Arginine (arginine)
- loratadine
- Lovaza (omega-3 polyunsaturated fatty acids)
- meloxicam
- metformin
- Metoprolol Tartrate (metoprolol)
- multivitamin with minerals
- olmesartan
- Pred Forte (prednisolone ophthalmic)
- rosuvastatin
- saw palmetto
- tadalafil
M-END alcohol/food interactions
There are 2 alcohol/food interactions with M-END (brompheniramine / hydrocodone / pseudoephedrine).
M-END disease interactions
There are 26 disease interactions with M-END (brompheniramine / hydrocodone / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
More about M-END (brompheniramine / hydrocodone / pseudoephedrine)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.